UBS Group’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58M | Buy |
2,229,245
+524,527
| +31% | +$13.6M | 0.01% | 1094 |
|
|
2025
Q1 | $41.7M | Buy |
1,704,718
+690,827
| +68% | +$16.9M | 0.01% | 1300 |
|
|
2024
Q4 | $29.1M | Buy |
1,013,891
+927,357
| +1,072% | +$26.6M | 0.01% | 1479 |
|
|
2024
Q3 | $3.26M | Buy |
86,534
+8,454
| +11% | +$319K | ﹤0.01% | 2629 |
|
|
2024
Q2 | $2.46M | Buy |
78,080
+54,757
| +235% | +$1.73M | ﹤0.01% | 2672 |
|
|
2024
Q1 | $1.02M | Buy |
+23,323
| New | +$1.02M | ﹤0.01% | 3536 |
|